Literature DB >> 23276772

Epidemiology of pneumococcal serotype 6A and 6C among invasive and carriage isolates from Alaska, 1986-2009.

Karen Rudolph1, Michael Bruce, Dana Bruden, Tammy Zulz, Jay Wenger, Alisa Reasonover, Marcella Harker-Jones, Debby Hurlburt, Thomas Hennessy.   

Abstract

We investigated serotype 6A/6C invasive pneumococcal disease (IPD) incidence, genetic diversity, and carriage before and after 7-valent pneumococcal conjugate vaccine (PCV7) introduction in Alaska. IPD cases (1986-2009) were identified through population-based laboratory surveillance. Isolates were initially serotyped by conventional methods, and 6C isolates were differentiated from 6A by polymerase chain reaction. Among invasive and carriage isolates initially typed as 6A, 35% and 50% were identified as 6C, respectively. IPD rates caused by serotype 6A or 6C among children <5 years did not change from the pre- to post-PCV7 period (P = 0.71 and P = 0.09, respectively). Multilocus sequence typing of IPD isolates revealed 28 sequence types. The proportion of serotype 6A carriage isolates decreased from 7.4% pre-PCV7 to 1.8% (P < 0.001) during 2008-2009; the proportion of serotype 6C carriage isolates increased from 3.0% to 8.4% (P = 0.004) among children <5 years. Continued surveillance is warranted to monitor changes in serotype distribution and prevalence. Published by Elsevier Inc.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23276772      PMCID: PMC4629818          DOI: 10.1016/j.diagmicrobio.2012.11.021

Source DB:  PubMed          Journal:  Diagn Microbiol Infect Dis        ISSN: 0732-8893            Impact factor:   2.803


  32 in total

1.  Reduction of nasopharyngeal carriage of Streptococcus pneumoniae after administration of a 9-valent pneumococcal conjugate vaccine to toddlers attending day care centers.

Authors:  Ron Dagan; Noga Givon-Lavi; Orly Zamir; Merav Sikuler-Cohen; Lior Guy; Jacob Janco; Pablo Yagupsky; Drora Fraser
Journal:  J Infect Dis       Date:  2002-03-04       Impact factor: 5.226

2.  Changes in antibiotic-prescribing practices and carriage of penicillin-resistant Streptococcus pneumoniae: A controlled intervention trial in rural Alaska.

Authors:  Thomas W Hennessy; Kenneth M Petersen; Dana Bruden; Alan J Parkinson; Debby Hurlburt; Marilyn Getty; Benjamin Schwartz; Jay C Butler
Journal:  Clin Infect Dis       Date:  2002-05-21       Impact factor: 9.079

3.  Pre- and post-conjugate vaccine epidemiology of pneumococcal serotype 6C invasive disease and carriage within Navajo and White Mountain Apache communities.

Authors:  Eugene V Millar; Fabiana C Pimenta; Alexis Roundtree; Delois Jackson; Maria da Gloria Carvalho; Mindy J Perilla; Raymond Reid; Mathuram Santosham; Cynthia G Whitney; Bernard W Beall; Katherine L O'Brien
Journal:  Clin Infect Dis       Date:  2010-10-29       Impact factor: 9.079

4.  Trends of invasive serotype 6C pneumococci in Spain: emergence of a new lineage.

Authors:  Dora Rolo; Asunción Fenoll; Carmen Ardanuy; Laura Calatayud; Meritxell Cubero; Adela G de la Campa; Josefina Liñares
Journal:  J Antimicrob Chemother       Date:  2011-05-31       Impact factor: 5.790

5.  Characterization of invasive Pneumococci of serogroup 6 from adults in Barcelona, Spain, in 1994 to 2008.

Authors:  Dora Rolo; Carmen Ardanuy; Laura Calatayud; Román Pallares; Immaculada Grau; Ernesto García; Asunción Fenoll; Rogelio Martín; Josefina Liñares
Journal:  J Clin Microbiol       Date:  2011-03-30       Impact factor: 5.948

6.  The 13-valent pneumococcal conjugate vaccine (PCV13) elicits cross-functional opsonophagocytic killing responses in humans to Streptococcus pneumoniae serotypes 6C and 7A.

Authors:  David Cooper; Xinhong Yu; Mohinder Sidhu; Moon H Nahm; Philip Fernsten; Kathrin U Jansen
Journal:  Vaccine       Date:  2011-07-18       Impact factor: 3.641

7.  Increase in prevalence of Streptococcus pneumoniae serotype 6C at Eight Children's Hospitals in the United States from 1993 to 2009.

Authors:  Morgan C Green; Edward O Mason; Sheldon L Kaplan; Linda B Lamberth; Stephanie H Stovall; Laurence B Givner; John S Bradley; Tina Q Tan; William J Barson; Jill A Hoffman; Philana Ling Lin; Kristina G Hulten
Journal:  J Clin Microbiol       Date:  2011-03-30       Impact factor: 5.948

8.  Efficacy of a pneumococcal conjugate vaccine against acute otitis media.

Authors:  J Eskola; T Kilpi; A Palmu; J Jokinen; J Haapakoski; E Herva; A Takala; H Käyhty; P Karma; R Kohberger; G Siber; P H Mäkelä
Journal:  N Engl J Med       Date:  2001-02-08       Impact factor: 91.245

9.  Indirect effect of conjugate vaccine on adult carriage of Streptococcus pneumoniae: an explanation of trends in invasive pneumococcal disease.

Authors:  Laura L Hammitt; Dana L Bruden; Jay C Butler; Henry C Baggett; Debby A Hurlburt; Alisa Reasonover; Thomas W Hennessy
Journal:  J Infect Dis       Date:  2006-04-27       Impact factor: 5.226

10.  The epidemiology of invasive pneumococcal disease in Alaska, 1986-1990--ethnic differences and opportunities for prevention.

Authors:  M Davidson; A J Parkinson; L R Bulkow; M A Fitzgerald; H V Peters; D J Parks
Journal:  J Infect Dis       Date:  1994-08       Impact factor: 5.226

View more
  2 in total

1.  Pneumococcal serotype-specific antibodies persist through early childhood after infant immunization: follow-up from a randomized controlled trial.

Authors:  Johannes Trück; Matthew D Snape; Florencia Tatangeli; Merryn Voysey; Ly-Mee Yu; Saul N Faust; Paul T Heath; Adam Finn; Andrew J Pollard
Journal:  PLoS One       Date:  2014-03-11       Impact factor: 3.240

2.  High nasopharyngeal carriage of non-vaccine serotypes in Western Australian aboriginal people following 10 years of pneumococcal conjugate vaccination.

Authors:  Deirdre A Collins; Anke Hoskins; Jacinta Bowman; Jade Jones; Natalie A Stemberger; Peter C Richmond; Amanda J Leach; Deborah Lehmann
Journal:  PLoS One       Date:  2013-12-03       Impact factor: 3.240

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.